Structure–activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3β inhibitor
摘要:
Design, synthesis and the GSK3 beta inhibitory activities of the 7-hydroxy benzimidazole analogs are described. The solid-phase synthetic route was also developed for preparation of the analogs consisting of the novel ATP competitive scaffold. In addition, the structure-activity relationship of the 7-hydroxy benzimidazole analogs and their biological activities are reported. (c) 2012 Elsevier Ltd. All rights reserved.
Structure–activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3β inhibitor
摘要:
Design, synthesis and the GSK3 beta inhibitory activities of the 7-hydroxy benzimidazole analogs are described. The solid-phase synthetic route was also developed for preparation of the analogs consisting of the novel ATP competitive scaffold. In addition, the structure-activity relationship of the 7-hydroxy benzimidazole analogs and their biological activities are reported. (c) 2012 Elsevier Ltd. All rights reserved.
[EN] 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES AND PBK INHIBITORS CONTAINING THE SAME<br/>[FR] DÉRIVÉS DE 7-HYDROXY-BENZO-IMIDAZOLE-4-YL-MÉTHANONE ET INHIBITEURS DE PBK LES CONTENANT
申请人:ONCOTHERAPY SCIENCE INC
公开号:WO2010051085A1
公开(公告)日:2010-05-06
7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives, which are useful for PBK inhibitors, are provided.
7-羟基苯并咪唑-4-基甲酮衍生物,用于PBK抑制剂。
[EN] BENZOIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING THE SAME<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLE ET INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE-3-BÊTA CONTENANT CEUX-CI
申请人:ONCOTHERAPY SCIENCE INC
公开号:WO2010014794A1
公开(公告)日:2010-02-04
Benzoimidazole Derivatives are provided. The compounds of the present invention are useful for Glycogen Synthase Kinase-3 Beta Inhibitors.
苯并咪唑衍生物已提供。本发明的化合物对于糖原合成酶激酶-3β抑制剂是有用的。
Amidine derivatives which are inhibitors of nitric oxide synthase
申请人:——
公开号:US20020137750A1
公开(公告)日:2002-09-26
There are provided novel compounds of formula (I)
1
wherein R
1
, R
2
, X, Y and Z are as defined in the Specification and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; tocether with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.
There are provided novel compounds of formula (I)
1
wherein R
1
, R
2
, R
3
, X and Z are as defined in the Specification and optical isomers, racemates and tautomers thereof and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase.
[EN] GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES<br/>[FR] INHIBITEURS DE GLYCOGÈNE SYNTHASE KINASE-3 BÊTA CONTENANT DES DÉRIVÉS DE 7-HYDROXY-BENZOIMIDAZOL-4-YL-MÉTHANONE
申请人:ONCOTHERAPY SCIENCE INC
公开号:WO2010058512A1
公开(公告)日:2010-05-27
GSK-3beta inhibitors comprising 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives are provided. For example, the inhibitors have following general formula (I).